Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
LegalZoom.com
LZ
$1.18B
| $684K | ﹤0.01% |
121,965
-56,030
| -31% | -$366K |
2021 Q3
20 quarters
|
|
3477
Evolent Health
EVH
$543M
| $682K | ﹤0.01% |
195,550
-269,596
| -58% | -$1.2M |
2015 Q2
45 quarters
|
|
3478
Ambiq Micro
AMBQ
$1B
| $682K | ﹤0.01% |
10,004
-10,997
| -52% | -$741K |
2025 Q3
4 quarters
|
|
3479
Starwood Property Trust
STWD
$4.79B
| $679K | ﹤0.01% |
50,265
-123,299
| -71% | -$1.97M |
2013 Q2
53 quarters
|
|
3480
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$344M
| $678K | ﹤0.01% |
4,307
-689
| -14% | -$108K |
2021 Q1
22 quarters
|
|
3481
Geron
GERN
$694M
| $676K | ﹤0.01% |
549,835
-276,381
| -33% | -$396K |
2013 Q2
53 quarters
|
|
3482
iShares Core MSCI Total International Stock ETF
IXUS
$58B
| $672K | ﹤0.01% |
7,075
-108,302
| -94% | -$10.4M |
2023 Q2
13 quarters
|
|
3483
CALL
Ionis Pharmaceuticals
IONS
$6.67B
| $670K | ﹤0.01% |
15,000
-136,300
| -90% | -$7.75M |
2024 Q3
8 quarters
|
|
|
3484
PUT
Ionis Pharmaceuticals
IONS
$6.67B
| $670K | ﹤0.01% |
15,000
-3,000
| -17% | -$170K |
2026 Q1
2 quarters
|
|
3485
Nelnet
NNI
$4.56B
| $668K | ﹤0.01% |
5,429
-9,438
| -63% | -$1.22M |
2013 Q2
53 quarters
|
|
3486
Grid Dynamics Holdings
GDYN
$1.11B
| $668K | ﹤0.01% |
84,712
-227,431
| -73% | -$1.63M |
2020 Q1
26 quarters
|
|
3487
IES Holdings
IESC
$7.17B
| $668K | ﹤0.01% |
2,079
-3,377
| -62% | -$1.12M |
2017 Q4
35 quarters
|
|
3488
Aebi Schmidt Holding AG
AEBI
$903M
| $667K | ﹤0.01% |
63,041
+44,308
| +237% | +$548K |
2025 Q3
4 quarters
|
|
3489
Red River Bancshares
RRBI
$709M
| $666K | ﹤0.01% |
6,665
-2,713
| -29% | -$272K |
2019 Q2
29 quarters
|
|
3490
Victory Capital Holdings
VCTR
$7.39B
| $664K | ﹤0.01% |
6,004
-59,657
| -91% | -$6.31M |
2019 Q4
27 quarters
|
|
3491
BigBear.ai
BBAI
$1.23B
| $662K | ﹤0.01% |
249,648
-315,851
| -56% | -$952K |
2023 Q1
14 quarters
|
|
3492
Ardent Health
ARDT
$1.83B
| $661K | ﹤0.01% |
63,921
-4,794
| -7% | -$51.4K |
2024 Q3
8 quarters
|
|
3493
Tandem Diabetes Care
TNDM
$1.33B
| $660K | ﹤0.01% |
40,473
+243
| +0.6% | +$4.56K |
2016 Q3
40 quarters
|
|
3494
Vanguard Materials ETF
VAW
$3.38B
| $660K | ﹤0.01% |
3,025
+103
| +4% | +$23.7K |
2013 Q2
53 quarters
|
|
3495
Santander
BSBR
$35.6B
| $657K | ﹤0.01% |
117,990
+101,945
| +635% | +$573K |
2026 Q2
1 quarter
|
|
3496
Central Pacific Financial
CPF
$999M
| $655K | ﹤0.01% |
18,239
-8,303
| -31% | -$317K |
2013 Q2
53 quarters
|
|
3497
USA Today Co
TDAY
$891M
| $654K | ﹤0.01% |
103,900
-137,178
| -57% | -$1.01M |
2014 Q1
50 quarters
|
|
3498
First Tracks Biotherapeutics
TRAX
$2.06B
| $652K | ﹤0.01% |
18,401
-17,798
| -49% | -$695K |
2026 Q2
1 quarter
|
|
3499
BlackLine
BL
$2B
| $650K | ﹤0.01% |
24,497
-25,666
| -51% | -$769K |
2017 Q4
35 quarters
|
|
3500
Heartland Express
HTLD
$829M
| $649K | ﹤0.01% |
55,888
-69,862
| -56% | -$908K |
2013 Q2
53 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.